Examples of using Inducer in English and their translations into Hungarian
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Programming
-
Official/political
-
Computer
The potential for interaction of glycerol phenylbutyrate as a CYP3A4 inducer and those products predominantly metabolised by the CYP3A4 pathway is possible.
Rifampicin is a strong CYP3A4 inducer and has been shown to cause a 92% decrease in indinavir AUC which can result in virological failure
Anidulafungin is not a clinically relevant substrate, inducer, or inhibitor of cytochrome P450 isoenzymes(1A2,
Entecavir is not a substrate, an inducer or an inhibitor of cytochrome P450(CYP450)
from your P.D.A. And we can make a null pulse inducer to delay the trigger signal in the land mine.
one week after the inducer treatment.
a moderate inhibitor, and an inducer of CYP3A4.
Results showed that Biobran MGN-3 is a potent TNF-α inducer and the effect was dose-dependent.
Rifampicin(600 mg daily), a potent inducer of CYP3A and CYP2B6, and an inducer of CYP2C9, CYP2C19, and CYP2C8, did not significantly change the pharmacokinetics of prasugrel.
particularly cytochrome 3A4: Mitotane is a hepatic enzyme inducer and it should be used with caution in case of concomitant use
the activation of phospholipases(2), which sequester themselves into unsaturated-rich microdomains and cleave arachidonic acid, a known HSP inducer.
In healthy volunteers receiving carbamazepine, a CYP3A4 inducer, at 100 mg twice daily for 3 days
A drug-drug interaction study assessing the effect of rifampicin, a potent CYP3A4 inducer, on the pharmacokinetics of bortezomib(injected intravenously),
If co-administration of a moderate CYP3A4 and/or PgP inhibitor or inducer cannot be avoided,
the potent UGT inducer, rifampicin,(repeated dose of 600 mg/ day)
In a clinical pharmacokinetic interaction study of healthy subjects pretreated with a strong CYP3A4 inducer rifampicin, 600 mg daily for 6 days followed by a single dose of abiraterone acetate 1,000 mg,
In the same drug-drug interaction study assessing the effect of dexamethasone, a weaker CYP3A4 inducer, on the pharmacokinetics of bortezomib(injected intravenously),
where the metabolite exposures decreased by up to 95% and CYP3A inducer, carbamazepine, where the metabolite exposures decreased by only up to 39%.
mushrooms also contain anti-virus Ingredient----interferon inducer----double-stranded RNA is one of the rare health foods.
Another molecule, the inducer, can bind to the repressor molecule,